维普期刊资源整合服务平台（V6.5）

20篇 您的检索式：作者名="Amonkar MM"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

	题名	作者	年代	出处	被引量
1	Impaet of lapatinib monotherapy on QOL and pain symptoms in patients with HER2 + relapsed or refractory inflammatory breast cancer 显示文摘	Kaufman B Wu Y Amonkar MM	2010	Curr Med Res Opin2010，26，5：	1
2	Impact of lapatinib plus trastuzumab versus single-agent lapatinib on quality of life of patients with trastuzumab-refractory HER2+ metastatic breast cancer显示文摘	Wu Y Amonkar MM Sherrill BH	2011	Ann Oncol2011，22，12：	1
3	Economic burden of resected squamous cell carcinoma of the head and neck in an incident cohort of patients in the UK显示文摘	Kim K Amonkar MM H Ogberg D	2011	Head Neck Oncol2011，3，：	1
4	Use of colonoscopy for colorectalogycancer screening:evidence from the 2000 national health interview survey显示文摘	Subramanian S Amonkar MM Hunt TL	2005	Cancer Epidemiology Biomarkers Prevention2005，14，2：	1
5	Surveillance patternsand polyp recurrence following diagnosis and excision of colorectalpolyps in a medicare population Cancer epidemiology biomarkersand prevention 显示文摘	Amonkar MM Hunt TL Zhou Z	2005	14 (2) : 417 -4212005，14，2：	1
6	Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis显示文摘	Cramer JA Amonkar MM Hebborn A	2005	Current Medical Research and Opinion2005，，：	1
7	Surveillance patterns and polyp recurrence following diagnosis andexcision of eoloreetal polyps in a medicare population 显示文摘	Amonkar MM Hunt TL Zhou Z	2005	Cancer Epidemiol Biomarkers Prey2005，14，：	1
8	Quality of life in hormone receptor-positive Her-2 + metastatic breast cancer patients during treatment with letrozole alone or in combination with lapatinib显示文摘	Sherrill B Amonkar MM Sherif B	2010	Oncolodist2010，15，9：	1
9	Systematic review of lap- atinib in combination with letrozole compared with other first-line treatments for hormone receptor positive (HR:) and HER2: advanced or metastatic breast cancer (MBC)显示文摘	Riemsma R Forbes CA Amonkar MM	2012	Curr Med Res Opin2012，28，8：	1
10	Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis显示文摘	Cramer JA Amonkar MM Hebbom A	2005	Curt Med Res Opin2005，21，12：	1
11	Compliance and persis- tence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis 显示文摘	Eramer JA Amonkar MM Hebbom A	2005	Curt Med Res Opin2005，21，12：	1
12	Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis显示文摘	Gramer JA Amonkar MM Hebbom A	2005	Current Medical Research and Opinion2005，21，12：	1
13	Surveillance patterns and polyp recurrence following diagnosis and excision of eoloreetal polyps in a medicare population 显示文摘	Amonkar MM Hunt TL Zhou Z	2005	Cancer Epidemlol Biomarkers Prev2005，14，2：	1
14	Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis显示文摘	Cramer JA Amonkar MM Hebborn A	2005	Current Medical Research and Opinion2005，，：	1
15	Surveilance patterns and polyp recurrence following diagnosis and excision of colorectal polyps in a medicare population显示文摘	Amonkar MM Hunt TL Zhou z	2005	Cancer Epidemiol Biomarkers Prev2005，14，2：	1
16	Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population显示文摘	Fernandes AW Madhavan SS Amonkar MM	2005	Clin Ther2005，27，5：	1
17	Quality-of-life and quality-adjusted survival(Q-TWiST) in patients receiving lapatinib in combination with paclitaxel as first-line treatment for metastatic breast cancer显示文摘	Sherrill B Di Leo A Amonkar MM	2010	Curr Med Res Opin2010，26，4：	1
18	Impact of lapatinib monotherapy on QOL and pain symptoms in patients with HER2+ relapsed or refractory inflammatory breast cancer显示文摘	Kaufman B Wu Y Amonkar MM	2010	Curr Med Res Opin2010，26，5：	1
19	Surveillance patterns and polyp recurrence following diagnosis andexcision of eolorectal polyps in amedicare population显示文摘	Amonkar MM Hunt TL Zhou Z		0，，：	1
20	Quality-adjusted survival analysis of first-line treatment of hormone-receptor-positive HER2+ metastatic breast cancer with letrozole alone or in combination with lapatinib显示文摘	Sherrill B Sherif B Amonkar MM	2011	Curr Med Res Opin2011，27，12：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示